dc.contributor.author | McGettigan, P | en_US |
dc.contributor.author | Roderick, P | en_US |
dc.contributor.author | Mahajan, R | en_US |
dc.contributor.author | Kadam, A | en_US |
dc.contributor.author | Pollock, AM | en_US |
dc.date.accessioned | 2015-12-18T10:26:23Z | |
dc.date.accessioned | 2016-05-16T14:03:03Z | |
dc.date.available | 2015-04-03 | en_US |
dc.date.issued | 2015-05 | en_US |
dc.date.submitted | 2016-02-25T17:18:21.097Z | |
dc.identifier.issn | 1549-1676 | en_US |
dc.identifier.other | ARTN e1001826 | en_US |
dc.identifier.other | ARTN e1001826 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/12349 | |
dc.relation.ispartof | PLOS MEDICINE | en_US |
dc.relation.replaces | http://qmro.qmul.ac.uk/xmlui/handle/123456789/9922 | |
dc.relation.replaces | 123456789/9922 | |
dc.rights | © 2015. This manuscript version is made available under the Creative Commons Attribution License 4.0 http://creativecommons.org/licenses/by/4.0/ | |
dc.title | Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1371/journal.pmed.1001826 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000355304100004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 12 | en_US |